Stay informed
about PROC
and
GR research
Leading oncologist video library
The Unmet Need in PROC
Glucocorticoid Receptor Activation and Chemotherapy Resistance
Expand your knowledge
Dive deeper into platinum-resistant ovarian cancer and glucocorticoid
receptor signaling.
GR Quick
Reference
See the connection between the
glucocorticoid system, ovarian cancer, and resistance.
glucocorticoid system, ovarian cancer, and resistance.
Download Now
Select
publications
See recent publications
relevant to platinum-resistant
ovarian cancer management.
relevant to platinum-resistant
ovarian cancer management.
Read Pubs
Visit the National
Comprehensive
Cancer
Network® (NCCN®)
Read more about management approaches to ovarian cancer and
platinum resistance.
platinum resistance.
Go
This information is provided solely as a resource for healthcare professionals and may include product uses not approved by the FDA.
Select publications
View key publications about platinum-resistant ovarian cancer.
Melhem A, et al. Clin Cancer Res. 2009.
Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues
Read Publication
Block TS, et al. Cancer Manag Res. 2017.
Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay
Read Publication
Mikosz C, et al. J Biol Chem. 2001.
Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, SGK-1*
Read Publication
